Sign up to save your podcasts
Or
Share The Lollipop War Has Begun
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Lollipop War Has Begun
Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.
Get $50 off your first job post at www.LinkedIn.com/Fool.
View all episodes
By The Motley Fool
4.7
16081,608 ratings
Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.
Get $50 off your first job post at www.LinkedIn.com/Fool.
More shows like MarketFoolery
View all
Mad Money w/ Jim Cramer
4,091 Listeners
Investing Insights
487 Listeners
Motley Fool Money
3,187 Listeners
Industry Focus
828 Listeners
Masters in Business
2,187 Listeners
Money For the Rest of Us
1,371 Listeners
We Study Billionaires - The Investor’s Podcast Network
3,377 Listeners
Motley Fool Answers
806 Listeners
InvestED: The Rule #1 Investing Podcast
1,492 Listeners
Rule Breaker Investing
930 Listeners
Invest Like the Best with Patrick O'Shaughnessy
2,285 Listeners
Bogleheads On Investing Podcast
581 Listeners
Investing With IBD
378 Listeners
The Long View
870 Listeners
Barron's Streetwise
1,534 Listeners
The Memo by Howard Marks
399 Listeners
The Investopedia Express with Caleb Silver
232 Listeners